Jun
2026
Pennsylvania Convention Center, Philadelphia
Visit us
stand 640

LAURUS LABS

Exhibitor at CPHI Americas 2026
About Us

In a little over 10 years Laurus has established itself as one of the largest and most progressive API manufacturers in the world.  Building on its established capabilities in chemistry, recently Laurus has embraced complete vertical integration with a formidable finished dosage capability, capacity dedicated to backward integration and also Synthesis R&D in India and USA.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    India
  • On CPHI since:
    2017
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Americas 2026
  • 2 Jun 2026 - 4 June 2026
  • Pennsylvania Convention Center, Philadelphia
  • Visit us at stand 640

Products Featured at CPHI Americas 2026

  • Active Pharmaceutical Ingredients

    Product Active Pharmaceutical Ingredients

    Building on our strong capabilities in chemical development and manufacturing, Laurus Labs has developed an in-house range of APIs and related intermediates. Focusing on chemistries where we can make a difference, Laurus combined innovation with efficiency by developing cost effective processes w...
  • Finished Dosage Form

    Product Finished Dosage Form

    Laurus is forward integrating into finished dosage forms (FDF) to create more value, generated through its cost effective processes and large capacities in the API business, for its customers.

    The Finished Dosage Form Development center is an integral part of Laurus R&D, comprising of Formul...
  • Laurus Synthesis

    Product Laurus Synthesis

    The core-strength of Laurus is its innovative, robust & scalable chemistry - making use of which, multiple developmental candidates of client organizations have been handled at all stages of drug lifecycle right from route identification through tocustom synthesis and from early clinical...